4,573 articles in this topic
A landmark study reveals how competing histone modifications act as a molecular toggle governing blood stem cell differentiation and tissue homeostasis.
The FDA expanded approval of Casgevy, a CRISPR-based gene therapy, to children aged 2+ with sickle cell disease, offering a potential cure.
The OPTIMA trial shows genomic testing could safely help more women with early breast cancer skip chemo, including premenopausal women.
A major global study finds BMI-linked gaps in blood pressure and cholesterol have nearly vanished for older adults — but young adults remain at elevated risk.
Tregzi, a personalized T cell therapy, wins FDA approval to reduce dangerous immune complications in blood cancer stem cell transplant patients.
A 25-year Lancet study finds adults over 40 with obesity now show cardiovascular markers rivaling normal-weight peers, thanks to medications.
From a 20% lifespan boost in mice to Alzheimer's glycosylation hallmarks, June's research roundup delivers dense longevity science.
A new review reveals how the deadenylase PARN governs telomerase RNA maturation, linking RNA decay to telomere length, aging, and disease.
A comprehensive review of inherited bone marrow failure, covering genetic causes, major syndromes, and the cytopenias that define them.
An AI-engineered antisense oligonucleotide slashes toxic progerin levels, reverses cardiovascular damage, and dramatically extends lifespan in progeria models.
Dasatinib + quercetin clears senescent kidney cells, restores anti-aging protein Klotho, and reverses transcriptional aging across multiple renal cell types.
A large multi-omics study confirms sarcopenia and osteoporosis fuel each other — and share genetic, protein, and metabolic pathways.
